Latest Insider Transactions at Medicinova Inc (MNOV)
This section provides a real-time view of insider transactions for Medicinova Inc (MNOV). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MEDICINOVA INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MEDICINOVA INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 28
2022
|
Hideki Nagao Director |
SELL
Open market or private sale
|
Direct |
6,754
-100.0%
|
$13,508
$2.25 P/Share
|
|
Nov 22
2022
|
Hideki Nagao Director |
SELL
Open market or private sale
|
Direct |
218
-3.13%
|
$436
$2.13 P/Share
|
|
Nov 21
2022
|
Hideki Nagao Director |
SELL
Open market or private sale
|
Direct |
5,365
-43.49%
|
$10,730
$2.18 P/Share
|
|
Nov 17
2022
|
Hideki Nagao Director |
SELL
Open market or private sale
|
Direct |
309
-2.44%
|
$618
$2.18 P/Share
|
|
Aug 23
2021
|
Kazuko Matsuda Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+15.67%
|
$120,000
$2.3 P/Share
|
|
Jul 09
2021
|
Yuichi Iwaki President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
39,583
+3.93%
|
$79,166
$2.54 P/Share
|
|
Jun 24
2021
|
Kazuko Matsuda Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
102,804
+18.0%
|
$205,608
$2.5 P/Share
|
|
May 19
2021
|
Geoffrey O Brien Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
43,318
+32.68%
|
$86,636
$2.5 P/Share
|
|
Mar 11
2021
|
Hideki Nagao Director |
SELL
Open market or private sale
|
Direct |
2,354
-15.69%
|
$16,478
$7.4 P/Share
|
|
Feb 25
2021
|
Yuichi Iwaki President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
86,250
+8.51%
|
$172,500
$2.46 P/Share
|